Novoglan Appoints iMEDicare as Exclusive Distributor in the UK and Republic of Ireland, Marking a Major Milestone in Men’s Health
In a ground-breaking move that promises to reshape the landscape of men’s health, Platigo Solutions, the manufacturer of Novoglan, the leading men’s health product for the management of phimosis and related conditions, is thrilled to announce its new partnership with iMEDicare Pelvic Health Company. Effective from 1st March 2024, this exclusive distribution agreement covers both the United Kingdom and the Republic of Ireland, positioning iMEDicare as the sole distributor of the innovative Novoglan products within these territories.
iMEDicare, renowned for its extensive expertise in pelvic and men’s sexual health, brings to the table a deep understanding of the needs and challenges in this space. With a long-standing reputation for excellence, iMEDicare boasts unparalleled connections with a network of urologists, andrologists, and their nursing teams, ensuring that Novoglan products are recommended by the best in the field.
This strategic alliance is set to significantly benefit the medical community and patients alike. It aims to support healthcare professionals in the effective treatment of phimosis, and enable patients to easily access Novoglan products through the iMEDicare online portal, backed by locally based customer service and care.
Andrew James, CEO and founder of Novoglan, expressed his enthusiasm about this partnership, highlighting it as a pivotal moment for the company. “We are thrilled to officially welcome iMEDicare as our partner to drive our clinical advocacy strategy, as their expertise in pelvic health solutions and supporting urology and andrology clinics in the UK is second to none. This partnership with iMEDicare is a testament to our commitment to improving the quality of life for men, reducing anxiety, and fostering better sexual health and relationships.”
Darren Breen of iMEDicare Pelvic Health Naturally echoed these sentiments, emphasizing the positive impact this collaboration will have on men’s health across the UK and Ireland. “The Novoglan medical device is not only innovative in the treatment of phimosis but is indeed groundbreaking as the leading non-surgical treatment for phimosis in men. Backed by independent clinical study results that have established a greater than 90% efficacy in patients, we are poised to make a significant difference in the lives of many.”
This partnership is a beacon of hope for men suffering from phimosis and related issues, offering them a clinically proven solution accompanied by unparalleled support and care.
For further details on this transformative partnership and the Novoglan range of products, please contact Andrew James at Novoglan or Darren Breen at iMEDicare Pelvic Health Naturally. Learn more above Novoglan here.
Contact Information: Andrew James - CEO, Novoglan
